Trials / Conditions / Neuroendocrine Cancer

Neuroendocrine Cancer

10 registered clinical trials studyying Neuroendocrine Cancer — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	DLL3-Targeted PET/CT in Neuroendocrine Carcinoma NCT07458906	The First Affiliated Hospital of Xiamen University	N/A
Recruiting	Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine NCT07080242	SystImmune Inc.	Phase 1
Recruiting	Ivonescimab in the Treatment of Multiple Advanced Tumors NCT06683846	Fudan University	Phase 2
Recruiting	Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinom NCT06283719	Suzhou Zelgen Biopharmaceuticals Co.,Ltd	Phase 1 / Phase 2
Completed	Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors NCT03290079	H. Lee Moffitt Cancer Center and Research Institute	Phase 2
Completed	Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers NCT02318784	SCRI Development Innovations, LLC	Phase 2
Unknown	68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors NCT02038738	Ochsner Health System	Phase 1 / Phase 2
Completed	Clinical Trial of the Impact of Treatment Consultation Recordings on Cancer Patient Outcomes NCT01866228	University of Manitoba	N/A
Completed	Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced C NCT00423254	Mannkind Corporation	Phase 1
Unknown	Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors NCT00178698	The University of Texas Health Science Center, Houston	Phase 2